Global and United States Small Interfering RNA (siRNA) Therapeutics Market Report & Forecast 2022-2028

Global and United States Small Interfering RNA (siRNA) Therapeutics Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Small Interfering RNA (siRNA) Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Small Interfering RNA (siRNA) Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size for the Year 2017-2028
1.3 Small Interfering RNA (siRNA) Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Small Interfering RNA (siRNA) Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Small Interfering RNA (siRNA) Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Small Interfering RNA (siRNA) Therapeutics Market Dynamics
1.4.1 Small Interfering RNA (siRNA) Therapeutics Industry Trends
1.4.2 Small Interfering RNA (siRNA) Therapeutics Market Drivers
1.4.3 Small Interfering RNA (siRNA) Therapeutics Market Challenges
1.4.4 Small Interfering RNA (siRNA) Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Small Interfering RNA (siRNA) Therapeutics by Type
2.1 Small Interfering RNA (siRNA) Therapeutics Market Segment by Type
2.1.1 Liposome Based Systemic Therapy
2.1.2 Nanoparticle Based Systemic Therapy
2.1.3 Other
2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2028)
2.4 United States Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2028)
3 Small Interfering RNA (siRNA) Therapeutics by Application
3.1 Small Interfering RNA (siRNA) Therapeutics Market Segment by Application
3.1.1 Hospital
3.1.2 Research Institutions
3.1.3 Pharmaceutical and Biotechnology Companies
3.1.4 Academic Institutions
3.1.5 Other
3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2028)
3.4 United States Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2028)
4 Global Small Interfering RNA (siRNA) Therapeutics Competitor Landscape by Company
4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Company
4.1.1 Top Global Small Interfering RNA (siRNA) Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue by Player (2017-2022)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Concentration Ratio (CR)
4.2.1 Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Small Interfering RNA (siRNA) Therapeutics in 2021
4.2.3 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Small Interfering RNA (siRNA) Therapeutics Headquarters, Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Small Interfering RNA (siRNA) Therapeutics Headquarters and Area Served
4.3.2 Global Small Interfering RNA (siRNA) Therapeutics Companies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Small Interfering RNA (siRNA) Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Small Interfering RNA (siRNA) Therapeutics Market Size by Company
4.5.1 Top Small Interfering RNA (siRNA) Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region
5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Small Interfering RNA (siRNA) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GE
7.1.1 GE Company Details
7.1.2 GE Business Overview
7.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction
7.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.1.5 GE Recent Development
7.2 Horizon Discovery
7.2.1 Horizon Discovery Company Details
7.2.2 Horizon Discovery Business Overview
7.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction
7.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.2.5 Horizon Discovery Recent Development
7.3 Thermo Scientific
7.3.1 Thermo Scientific Company Details
7.3.2 Thermo Scientific Business Overview
7.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction
7.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.3.5 Thermo Scientific Recent Development
7.4 OPKO Health
7.4.1 OPKO Health Company Details
7.4.2 OPKO Health Business Overview
7.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction
7.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.4.5 OPKO Health Recent Development
7.5 AInylam Pharmaceuticals
7.5.1 AInylam Pharmaceuticals Company Details
7.5.2 AInylam Pharmaceuticals Business Overview
7.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction
7.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.5.5 AInylam Pharmaceuticals Recent Development
7.6 Arrowhead Research
7.6.1 Arrowhead Research Company Details
7.6.2 Arrowhead Research Business Overview
7.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction
7.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.6.5 Arrowhead Research Recent Development
7.7 Sanofi Genzyme
7.7.1 Sanofi Genzyme Company Details
7.7.2 Sanofi Genzyme Business Overview
7.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction
7.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.7.5 Sanofi Genzyme Recent Development
7.8 Genecon Biotechnologies
7.8.1 Genecon Biotechnologies Company Details
7.8.2 Genecon Biotechnologies Business Overview
7.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction
7.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.8.5 Genecon Biotechnologies Recent Development
7.9 Arbutus Biopharma
7.9.1 Arbutus Biopharma Company Details
7.9.2 Arbutus Biopharma Business Overview
7.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction
7.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.9.5 Arbutus Biopharma Recent Development
7.10 Silent Therapeutics
7.10.1 Silent Therapeutics Company Details
7.10.2 Silent Therapeutics Business Overview
7.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction
7.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.10.5 Silent Therapeutics Recent Development
7.11 Sylentis
7.11.1 Sylentis Company Details
7.11.2 Sylentis Business Overview
7.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction
7.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
7.11.5 Sylentis Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Small Interfering RNA (siRNA) Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Small Interfering RNA (siRNA) Therapeutics Market Trends
Table 3. Small Interfering RNA (siRNA) Therapeutics Market Drivers
Table 4. Small Interfering RNA (siRNA) Therapeutics Market Challenges
Table 5. Small Interfering RNA (siRNA) Therapeutics Market Restraints
Table 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Small Interfering RNA (siRNA) Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Small Interfering RNA (siRNA) Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Small Interfering RNA (siRNA) Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Small Interfering RNA (siRNA) Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Small Interfering RNA (siRNA) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2021)
Table 15. Top Players of Small Interfering RNA (siRNA) Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Small Interfering RNA (siRNA) Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Small Interfering RNA (siRNA) Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Small Interfering RNA (siRNA) Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Small Interfering RNA (siRNA) Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Small Interfering RNA (siRNA) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Small Interfering RNA (siRNA) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Small Interfering RNA (siRNA) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. GE Company Details
Table 31. GE Business Overview
Table 32. GE Small Interfering RNA (siRNA) Therapeutics Product
Table 33. GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 34. GE Recent Development
Table 35. Horizon Discovery Company Details
Table 36. Horizon Discovery Business Overview
Table 37. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product
Table 38. Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Horizon Discovery Recent Development
Table 40. Thermo Scientific Company Details
Table 41. Thermo Scientific Business Overview
Table 42. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product
Table 43. Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Thermo Scientific Recent Development
Table 45. OPKO Health Company Details
Table 46. OPKO Health Business Overview
Table 47. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product
Table 48. OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 49. OPKO Health Recent Development
Table 50. AInylam Pharmaceuticals Company Details
Table 51. AInylam Pharmaceuticals Business Overview
Table 52. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product
Table 53. AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 54. AInylam Pharmaceuticals Recent Development
Table 55. Arrowhead Research Company Details
Table 56. Arrowhead Research Business Overview
Table 57. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product
Table 58. Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Arrowhead Research Recent Development
Table 60. Sanofi Genzyme Company Details
Table 61. Sanofi Genzyme Business Overview
Table 62. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product
Table 63. Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Sanofi Genzyme Recent Development
Table 65. Genecon Biotechnologies Company Details
Table 66. Genecon Biotechnologies Business Overview
Table 67. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product
Table 68. Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Genecon Biotechnologies Recent Development
Table 70. Arbutus Biopharma Company Details
Table 71. Arbutus Biopharma Business Overview
Table 72. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product
Table 73. Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Arbutus Biopharma Recent Development
Table 75. Silent Therapeutics Company Details
Table 76. Silent Therapeutics Business Overview
Table 77. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product
Table 78. Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Silent Therapeutics Recent Development
Table 80. Sylentis Company Details
Table 81. Sylentis Business Overview
Table 82. Sylentis Small Interfering RNA (siRNA) Therapeutics Product
Table 83. Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Sylentis Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Interfering RNA (siRNA) Therapeutics Product Picture
Figure 2. Global Small Interfering RNA (siRNA) Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Small Interfering RNA (siRNA) Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Small Interfering RNA (siRNA) Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Small Interfering RNA (siRNA) Therapeutics Market Share in Global 2017-2028
Figure 7. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
Figure 8. Product Picture of Liposome Based Systemic Therapy
Figure 9. Product Picture of Nanoparticle Based Systemic Therapy
Figure 10. Product Picture of Other
Figure 11. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type in 2022 & 2028
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2017-2028)
Figure 14. United States Small Interfering RNA (siRNA) Therapeutics Market Share by Type in 2022 & 2028
Figure 15. United States Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Research Institutions
Figure 19. Product Picture of Pharmaceutical and Biotechnology Companies
Figure 20. Product Picture of Academic Institutions
Figure 21. Product Picture of Other
Figure 22. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application in 2022 & 2028
Figure 23. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2017-2028)
Figure 25. United States Small Interfering RNA (siRNA) Therapeutics Market Share by Application in 2022 & 2028
Figure 26. United States Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2017-2028)
Figure 28. North America Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. GE Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 57. Horizon Discovery Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 58. Thermo Scientific Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 59. OPKO Health Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 60. AInylam Pharmaceuticals Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 61. Arrowhead Research Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 62. Sanofi Genzyme Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 63. Genecon Biotechnologies Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 64. Arbutus Biopharma Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 65. Silent Therapeutics Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 66. Sylentis Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs